Healthcare reform

Mark Farrah Associates Assessed Annual Health Insurance Enrollment Trends

Retrieved on: 
Tuesday, May 4, 2021
Banking, Professional services, Other Health, Health, Publishing, Healthcare reform, Public relations, Investor relations, Communications, Public policy, Government, Insurance, Finance, Healthcare reform in the United States, Federal assistance in the United States, Presidency of Lyndon B. Johnson, Child poverty, Medicaid, Medicare, Health insurance, Health, United States, Government

b'Mark Farrah Associates (MFA), www.markfarrah.com , released a year-end 2020 health insurance segment enrollment update.

Key Points: 
  • b'Mark Farrah Associates (MFA), www.markfarrah.com , released a year-end 2020 health insurance segment enrollment update.
  • MFA compared membership between 4th quarter 2019 with 4th quarter 2020 to provide greater insight into enrollment trends for the Individual, Group, Medicare Advantage, and Medicaid insurance segments.\nAs of December 31, 2020, approximately 296 million people received medical coverage from U.S. health insurers.
  • In addition, the individual health insurance market and Medicaid also experienced marked membership increases.
  • Committed to simplifying analysis of health insurance business, our products include: Health Coverage Portal\xe2\x84\xa2 , Medicare Business Online\xe2\x84\xa2 , Medicare Benefits Analyzer\xe2\x84\xa2 , County Health Coverage\xe2\x84\xa2 , Health Plans USA\xe2\x84\xa2 and 5500 Employer Health Plus .

Lawrence J. Ellison Institute for Transformative Medicine of USC Launches Policy Department

Retrieved on: 
Tuesday, May 4, 2021
Research, Managed care, General Health, Oncology, White House, Federal Government, State, Local, Healthcare reform, Public policy, Other Policy Issues, Science, Health, Public policy, Government, America's Cup, Larry Ellison, Oracle Corporation, SailGP, Tesla, Inc., Doctor of Public Health, Seidman, Economy of the United States, Businesspeople, Technology

b'The Lawrence J. Ellison Institute for Transformative Medicine of USC (\xe2\x80\x9cEllison Institute\xe2\x80\x9d) is pleased to announce today the formation of a Policy Department and the hire of Gabriel Seidman, DrPH, as Director of Policy.\nThis press release features multimedia.

Key Points: 
  • b'The Lawrence J. Ellison Institute for Transformative Medicine of USC (\xe2\x80\x9cEllison Institute\xe2\x80\x9d) is pleased to announce today the formation of a Policy Department and the hire of Gabriel Seidman, DrPH, as Director of Policy.\nThis press release features multimedia.
  • \xe2\x80\x9cHealthcare faces enormous challenges, including with the ongoing pandemic and continued health inequities, but there are also exciting opportunities for change with technology, science, and policy innovation.
  • The Ellison Institute has a unique platform to seize the opportunities.\xe2\x80\x9d\nDr.
  • Gabriel Seidman brings extensive experience in strategic thinking, public-private partnerships, policy design, and management to the Ellison Institute.

ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring

Retrieved on: 
Tuesday, May 4, 2021
Public policy, Government, Healthcare reform, General Health, Health, Health sciences, Clinical research, Health, Medical research, Pharmaceutical industry, Clinical pharmacology, Clinical trial, Design of experiments, Clinical, Patient safety

b'Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial quality.

Key Points: 
  • b'Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial quality.
  • To better understand implementation across the industry, the Association of Clinical Research Organizations (ACRO) conducted a landscape survey of RBM implementation across 6,513 clinical trials that were ongoing in 2019 and compiled the information in a comprehensive report.\nAfter an unprecedented year, the clinical research industry has proved innovative, even in difficult circumstances.
  • Through its member companies, ACRO helps improve the quality, efficiency, and safety of biomedical research.
  • ACRO member companies operate in more than 100 countries across the globe and conduct or support the conduct of the majority of clinical trials worldwide.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210504005513/en/\n'

Mirador Global® Hires Two Key Execs to Further Expand Global Commercialization Consulting Services and Deepen Oncology Experience

Retrieved on: 
Tuesday, May 4, 2021
Consulting, Public policy, Government, Healthcare reform, Professional services, Small business, Biotechnology, Health, Pharmaceutical, Oncology, Oncology, Chemotherapy, Health, MIRADOR Global, COEUS Holdings, MIRADOR GLOBAL, COEUS HOLDINGS

Kaylor Kowash, RPh, MBA was brought on as VP, Oncology Commercial Strategy and Christian Bennett will serve as VP, Global Market Access Strategy.

Key Points: 
  • Kaylor Kowash, RPh, MBA was brought on as VP, Oncology Commercial Strategy and Christian Bennett will serve as VP, Global Market Access Strategy.
  • With 20+ years in oncology, Kowash has worked on ten brands in oncology including targeted and hormonal therapies, immuno-oncology, and chemotherapy.
  • Prior to joining MIRADOR Global he was an SVP, Managing Director, of Precision Advisors (a Global market access strategy group).
  • The company provides its clients with a bio-pharma line of sight unlike any other unique to MIRADOR Global.

Congresswoman Points to “Glaring Health Disparities in Detroit” at CareAdvisors/Detroit NAHSE Event

Retrieved on: 
Saturday, May 1, 2021
Other Consumer, Technology, Public policy, Government, Healthcare reform, Software, Health, Consumer, General Health, Public policy, Asia, Countries, Continents, Biotechnology, Vaccination, ASEAN, Myanmar

\xe2\x80\x9cEven with the vaccine, we are now facing another hurdle: we're less likely to receive the shot in our arms.

Key Points: 
  • \xe2\x80\x9cEven with the vaccine, we are now facing another hurdle: we're less likely to receive the shot in our arms.
  • We have lower vaccination rates than any other group.
  • Our team previously built one of the largest navigation programs in the nation, helping more than one million Illinois residents enroll in social services and gain access to resources.
  • For more information, visit care-advisors.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210430005651/en/\n"

'Pharmacy Benefit Manipulators?' - AHF to Target PBM Abuse in New Campaign

Retrieved on: 
Thursday, April 29, 2021
Social media, White House, Federal Government, Public policy, Insurance, Healthcare reform, Advertising, Pharmaceutical, Communications, General Health, Professional services, Philanthropy, Congressional News, Views, Public policy, Government, Foundation, AIDS, Health, Medicinal chemistry, Pharmacy, Symbols, Specialty pharmacy, Applied sciences, Articles, Branches of science

These mergers create megafirms that are rife with conflicts of interest.

Key Points: 
  • These mergers create megafirms that are rife with conflicts of interest.
  • They distort the market by locking out competing independent retail and specialty pharmacies.
  • The megafirms get richer and none of the profits go back to the patient,\xe2\x80\x9d added Scott Carruthers, Chief of Pharmacy and Senior Manager for AHF.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth and follow us @aidshealthcare .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210429005850/en/\n'

Specific Diagnostics Awarded Grant by the Department of Defense (DoD) to use Reveal for the Rapid Determination of the Antimicrobial Effectiveness of Bacteriophage

Retrieved on: 
Thursday, April 29, 2021
Public policy, Government, Health, Healthcare reform, Infectious diseases, Other Policy Issues, Pharmaceutical, Biotechnology, Health sciences, Health, Articles, Pharmaceuticals policy, Veterinary medicine, Antimicrobial resistance, Evolutionary biology, Drug resistance, Phage therapy, Antibiotic, Bacteriophage

With bacteria evolving resistance to antibiotics, driven in part by overuse, bacteriophage therapy represents a distinct and promising alternative to antibiotic therapy.\n\xe2\x80\x9cIn the age of antibiotic resistance, alternatives to antibiotics are increasingly needed,\xe2\x80\x9d said Dr. Paul A. Rhodes, Specific\xe2\x80\x99s CEO.

Key Points: 
  • With bacteria evolving resistance to antibiotics, driven in part by overuse, bacteriophage therapy represents a distinct and promising alternative to antibiotic therapy.\n\xe2\x80\x9cIn the age of antibiotic resistance, alternatives to antibiotics are increasingly needed,\xe2\x80\x9d said Dr. Paul A. Rhodes, Specific\xe2\x80\x99s CEO.
  • Its first commercial application applies this fundamental new capability to the rapid determination of antimicrobial susceptibility directly from positive blood cultures, as well as isolate dilutions.
  • Specific is based in Mountain View, CA.
  • For press inquiries, please contact: Jeff Holman, [email protected]\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210429005732/en/\n'

IMV Inc. to Announce First Quarter 2021 Results and Host a Conference Call and Webcast on May 12, 2021

Retrieved on: 
Thursday, April 29, 2021
Other Health, Research, General Health, Pharmaceutical, Oncology, Healthcare reform, Genetics, Science, Biotechnology, Other Science, Health, Public policy, Government, Communication, Forward-looking statement, LinkedIn, Digital Picture Exchange, Articles, Human resource management, Labor

IMV is pioneering a new class of cancer-targeted immunotherapies and vaccines based on the Company\xe2\x80\x99s proprietary delivery platform (DPX).

Key Points: 
  • IMV is pioneering a new class of cancer-targeted immunotherapies and vaccines based on the Company\xe2\x80\x99s proprietary delivery platform (DPX).
  • Visit www.imv-inc.com and connect with us on Twitter and LinkedIn .\nThis press release contains forward-looking information under applicable securities law.
  • All information that addresses activities or developments that we expect to occur in the future is forward-looking information.
  • Forward-looking statements are based on the estimates and opinions of management on the date the statements are made.

Orange County, North Carolina Selects Everbridge To Help Manage Vaccine Distribution

Retrieved on: 
Tuesday, April 27, 2021
Technology, Health, General Health, State, Local, Healthcare reform, Security, Telecommunications, Infectious diseases, Software, Public policy, Government, Mobile, Wireless, Medical research, Vaccination, Vaccine, Virology, COVID-19 vaccine, Carrboro, North Carolina, Orange County, North Carolina, Medical specialties, Medicine, Health sciences

b'Everbridge , Inc. (NASDAQ: EVBG), the global leader in critical event management ( CEM ), today announced that Orange County , North Carolina selected the company\xe2\x80\x99s Vaccine Distribution platform to better coordinate and administer the COVID-19 vaccine.

Key Points: 
  • b'Everbridge , Inc. (NASDAQ: EVBG), the global leader in critical event management ( CEM ), today announced that Orange County , North Carolina selected the company\xe2\x80\x99s Vaccine Distribution platform to better coordinate and administer the COVID-19 vaccine.
  • View the full release here: https://www.businesswire.com/news/home/20210427005657/en/\nOrange County, North Carolina Selects Everbridge To Help Manage Vaccine Distribution (Graphic: Business Wire)\nThe County \xe2\x80\x93 home to 150,000 people and the city of Chapel Hill, the University of North Carolina and the towns of Carrboro and Hillsborough \xe2\x80\x93 recently opened vaccine eligibility to everyone 16 and over.
  • The offering also provides governments with a single, unified platform to expedite vaccine coordination, communication and distribution for residents.
  • All other product or company names mentioned are the property of their respective owners.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210427005657/en/\n'

Public Service Announcement Airs During Oscars, Featuring Susan Sarandon and Cynthia Erivo, Proclaiming Prices Are Now a Patient’s Right

Retrieved on: 
Monday, April 26, 2021
General Health, Public policy, Government, Healthcare reform, Philanthropy, General Entertainment, Film & Motion Pictures, Celebrity, Social media, Entertainment, Other Communications, Health, Events, Concerts, Other Philanthropy, Public relations, Investor relations, Advertising, Communications, Public policy, Health policy in the United States, Chargemaster, Health insurance in the United States, Healthcare in the United States

Following a new law at the start of 2021, hospitals must provide clear and upfront pricing to patients.

Key Points: 
  • Following a new law at the start of 2021, hospitals must provide clear and upfront pricing to patients.
  • It\xe2\x80\x99s our right to know hospital prices,\xe2\x80\x9d declares Susan Sarandon in the PSA.\n\xe2\x80\x9cThe current hospital system creates debt that we did not expect so therefore we could not prepare for.
  • On January 1, 2021, a new healthcare rule mandates that all hospitals must finally publish their real prices online.
  • All Americans now have the right to see real prices before we receive care.